Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Wolff

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Bone Marrow Transplantation|March 20, 1999
High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell originR S Stein, J P Greer, S Goodman, et al.
American Journal of Clinical Pathology|January 1, 1997
Recurrent Hodgkin's disease after bone marrow transplantationI Shahab, J P Greer, T A Beeker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Etoposide kinetics in patients with obstructive jaundiceK R Hande, S N Wolff, F A Greco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1996
Nocardial infections in bone marrow transplant recipientsC Chouciño, S A Goodman, J P Greer, et al.
Blood|August 1, 1983
High-dose cytosine arabinoside therapy for refractory leukemiaR H Herzig, S N Wolff, H M Lazarus, et al.
Annals of Internal Medicine|February 1, 1988
Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief durationJ D Hainsworth, W W Grosh, L S Burnett, et al.
Seminars in Oncology|June 1, 1987
Central nervous system effects of high-dose cytosine arabinosideR H Herzig, G P Herzig, S N Wolff, et al.
Seminars in Oncology|March 1, 1985
High-dose etoposide (VP-16) in small-cell lung cancerF A Greco, D H Johnson, K R Hande, et al.
Leukemia|November 1, 1992
High-dose cytosine arabinoside for the treatment of acute myeloid leukemia. Studies of the North American Marrow Transplant GroupS N Wolff, R A Brown, J W Fay, et al.
Cancer Treatment Reports|August 1, 1986
Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosisJ D Hainsworth, S N Wolff, R S Stein, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|March 20, 1999
High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell originR S Stein, J P Greer, S Goodman, et al.
American Journal of Clinical Pathology|January 1, 1997
Recurrent Hodgkin's disease after bone marrow transplantationI Shahab, J P Greer, T A Beeker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Etoposide kinetics in patients with obstructive jaundiceK R Hande, S N Wolff, F A Greco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1996
Nocardial infections in bone marrow transplant recipientsC Chouciño, S A Goodman, J P Greer, et al.
Blood|August 1, 1983
High-dose cytosine arabinoside therapy for refractory leukemiaR H Herzig, S N Wolff, H M Lazarus, et al.
Annals of Internal Medicine|February 1, 1988
Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief durationJ D Hainsworth, W W Grosh, L S Burnett, et al.
Seminars in Oncology|June 1, 1987
Central nervous system effects of high-dose cytosine arabinosideR H Herzig, G P Herzig, S N Wolff, et al.
Seminars in Oncology|March 1, 1985
High-dose etoposide (VP-16) in small-cell lung cancerF A Greco, D H Johnson, K R Hande, et al.
Leukemia|November 1, 1992
High-dose cytosine arabinoside for the treatment of acute myeloid leukemia. Studies of the North American Marrow Transplant GroupS N Wolff, R A Brown, J W Fay, et al.
Cancer Treatment Reports|August 1, 1986
Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosisJ D Hainsworth, S N Wolff, R S Stein, et al.
Pageof 10